World AIDS Day: why HIV infections are still so hard to treat

Explore the enduring challenges of treating HIV, its unique properties, and the progress made since the virus's discovery.

Atea Pharmaceuticals Presents New Data Supporting the Fixed-Dose Combination of Bemnifosbuvir and Ruzasvir as a Potential Best-in-Class Regimen for Treatment of Hepatitis C ...

Detailed price information for Atea Pharmaceuticals Inc (AVIR-Q) from The Globe and Mail including charting and trades.

Burundi's fight against AIDS hit hard by end of US funding: 'We are in survival mode'

In this East African country, one of the poorest in the world, the elimination of US aid and the overall reduction in international funding have had an immediate impact on the fight against HIV and ...

CDC advisers could reverse newborn hepatitis B vaccine recommendations

Hepatitis B vaccines given at birth have essentially eliminated the disease in kids. A vote this week could upend that ...

The Journey To Hepatitis B Elimination Through Innovation, Early Testing, And Scientific Discovery

As hepatitis B research progresses, achieving higher functional cure rates is becoming more feasible. It is vital that ...

New method reveals how human cells initiate DNA replication

When cells proliferate, genomic DNA is precisely duplicated once per cell cycle. Abnormalities in this DNA replication process can cause alterations in genomic DNA, promoting cellular ageing, cancer, ...